文献速递临床试验与 GCP

出生6小时后启动治疗性低温对缺氧缺血性脑病新生儿死亡或残疾的影响:一项随机临床试验

Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2017-01-01

该随机临床试验纳入胎龄36周及以上、出生后6至24小时的中重度缺氧缺血性脑病新生儿,比较33.5°C低温治疗96小时与37.0°C非低温治疗的结局。主要复合结局为18至22月龄死亡或残疾,低温组78例中19例(24.4%)发生,非低温组79例中22例(27.9%)发生(绝对差3.5%,95%CI -1%至17%)。贝叶斯分析显示低温组死亡或残疾降低的后验概率为76%(校正后验风险比0.86,95%可信区间0.58-1.29),低温可能获益但有效性存在不确定性。

要点

  • 出生6至24小时启动低温治疗,死亡或残疾降低的后验概率为76%。
  • 低温组主要结局24.4% vs 非低温组27.9%,绝对差3.5%(95%CI -1%至17%)。
  • 低温使死亡或残疾至少降低2%的概率为64%,有效性存在不确定性。

核心结论

  • 对于胎龄36周及以上的缺氧缺血性脑病新生儿,出生6至24小时启动低温治疗相比非低温治疗,死亡或残疾有任何降低的后验概率为76%,至少降低2%的概率为64%。
  • 出生6至24小时启动低温治疗可能获益,但有效性存在不确定性。

研究设计与样本

  • 随机临床试验,2008年4月至2016年6月在美国21个新生儿研究网络中心开展。
  • 纳入胎龄36周及以上、出生后6至24小时入组的中度或重度缺氧缺血性脑病新生儿,预设贝叶斯分析。
  • 168例婴儿接受目标食管温度管理:83例低温组维持33.5°C(可接受范围33°C-34°C)96小时后复温,85例非低温组维持37.0°C(可接受范围36.5°C-37.3°C)。

主要发现

  • 低温组和非低温组平均(标准差)胎龄分别为39(2)周和39(1)周,男性分别为47/83(57%)和55/85(65%)。
  • 两组出生时均有酸血症,多以中度脑病转入治疗中心,随机化平均(标准差)时间分别为16(5)小时和15(5)小时。
  • 主要结局发生在低温组78例中的19例(24.4%)和非低温组79例中的22例(27.9%),绝对差3.5%(95%CI -1%至17%)。
  • 采用中性先验的贝叶斯分析显示,低温组相对非低温组死亡或残疾降低的后验概率为76%(校正后验风险比0.86,95%可信区间0.58-1.29)。
  • 低温组死亡或残疾至少比非低温组低1%、2%、3%的概率分别为71%、64%、56%。

临床怎么用

  • 原文未据此给出推荐,结论指出出生6至24小时启动低温治疗可能获益但有效性存在不确定性。

局限性

  • 预期样本量有限,预设了贝叶斯分析。
  • 低温治疗的有效性存在不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hypothermia initiated at less than 6 hours after birth reduces death or disability for infants with hypoxic-ischemic encephalopathy at 36 weeks' or later gestation. To our knowledge, hypothermia trials have not been performed in infants presenting after 6 hours. OBJECTIVE: To estimate the probability that hypothermia initiated at 6 to 24 hours after birth reduces the risk of death or disability at 18 months among infants with hypoxic-ischemic encephalopathy. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial was conducted between April 2008 and June 2016 among infants at 36 weeks' or later gestation with moderate or severe hypoxic-ischemic encephalopathy enrolled at 6 to 24 hours after birth. Twenty-one US Neonatal Research Network centers participated. Bayesian analyses were prespecified given the anticipated limited sample size. INTERVENTIONS: Targeted esophageal temperature was used in 168 infants. Eighty-three hypothermic infants were maintained at 33.5°C (acceptable range, 33°C-34°C) for 96 hours and then rewarmed. Eighty-five noncooled infants were maintained at 37.0°C (acceptable range, 36.5°C-37.3°C). MAIN OUTCOMES AND MEASURES: The composite of death or disability (moderate or severe) at 18 to 22 months adjusted for level of encephalopathy and age at randomization. RESULTS: Hypothermic and noncooled infants were term (mean [SD], 39 [2] and 39 [1] weeks' gestation, respectively), and 47 of 83 (57%) and 55 of 85 (65%) were male, respectively. Both groups were acidemic at birth, predominantly transferred to the treating center with moderate encephalopathy, and were randomized at a mean (SD) of 16 (5) and 15 (5) hours for hypothermic and noncooled groups, respectively. The primary outcome occurred in 19 of 78 hypothermic infants (24.4%) and 22 of 79 noncooled infants (27.9%) (absolute difference, 3.5%; 95% CI, -1% to 17%). Bayesian analysis using a neutral prior indicated a 76% posterior probability of reduced death or disability with hypothermia relative to the noncooled group (adjusted posterior risk ratio, 0.86; 95% credible interval, 0.58-1.29). The probability that death or disability in cooled infants was at least 1%, 2%, or 3% less than noncooled infants was 71%, 64%, and 56%, respectively. CONCLUSIONS AND RELEVANCE: Among term infants with hypoxic-ischemic encephalopathy, hypothermia initiated at 6 to 24 hours after birth compared with noncooling resulted in a 76% probability of any reduction in death or disability, and a 64% probability of at least 2% less death or disability at 18 to 22 months. Hypothermia initiated at 6 to 24 hours after birth may have benefit but there is uncertainty in its effectiveness. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00614744.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Laptook AR, Shankaran S, Tyson JE, et al. Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial. JAMA. 2017. PMID: 29067428. doi:10.1001/jama.2017.14972

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。